2025 Update in Hematology and Medical Oncology

Name: 2025 Update in Hematology and Medical Oncology
SKU: 25132
Availability: InStock

$150.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

Format: 47 MP4 + 47 VTT + 47 PDF files

Category: Hematology / Oncology Tag: ONCOLOGY-HEMATOLOGY

Description

Specialties

Specialties – Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology, Radiation Oncology, Surgical Oncology

Overview

The 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology, condensed into an intensive three-and-a-half-day virtual program, provides a thorough and up-to-date review of the diagnosis, staging, and management of neoplastic diseases, encompassing both solid tumors and hematologic malignancies. Lectures and discussions focus on disease-specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

This course is a live virtual event designed for medical oncology professionals, including physicians, nurses, pharmacists, fellows, and residents. It aims to help participants effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology.

Participants will also receive access to an online syllabus featuring select PDFs of presentation slides and video recordings of the lectures.

Objectives

At the conclusion of this course, attendees will be able to:

Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
Prepare for ABIM examinations in medical oncology and hematology.

Schedule

Friday, March 7, 2025

Relevant Financial Relationships

9:00AM – 9:10AM

Colon Cancer
9:15AM – 10:00AM
Leonard B Saltz, MD

Melanoma
10:00AM – 10:45AM
Michael Postow, MD

Kidney Cancer
10:45AM – 11:30AM
Robert Motzer, MD

Prostate Cancer
11:30AM – 12:15PM
Susan Slovin, MD, PhD

Mesothelioma
12:15PM – 1:00PM
Michael Offin, MD

Urothelial Cancer
1:15PM – 2:00PM
Gopakumar Iyer, MD

Testis Cancer
2:00PM – 2:45PM
Darren Feldman, MD

Uterine, Cervix, and Other Gynecologic Cancers
2:45PM – 3:30PM
Carol Aghajanian, MD

Ovarian Cancer
3:45PM – 4:30PM
Rachel Grisham, MD

Breast Cancer Surgery
4:30PM – 5:00PM
Anita Mamtani, MD

Breast Cancer Radiation Therapy
5:00PM – 5:30PM
Lior Braunstein, MD

Hereditary Cancer Genetics
5:30PM – 6:00PM
Zsofia Stadler, MD

Saturday, March 8, 2025

Small Cell Lung Cancer
7:00AM – 7:30AM
Alissa Cooper, MD

HER2-Positive Breast Cancer
7:30AM – 8:20AM
Joshua Drago, MD

Triple-Negative Breast Cancer
8:20AM – 9:10AM
Rachel Sanford, MD

Hormone Receptor-Positive Breast Cancer
9:10AM – 10:00AM
Devika Gajria, MD

Carcinoma of Unknown Primary
10:00AM – 10:30AM
Anna Mary Varghese, MD

Hepatocellular Cancer and Cholangiocarcinoma
10:45AM – 11:30AM
Ghassan K Abou-Alfa, MD, JD, MBA

Pancreatic and Neuroendocrine Cancers
11:30AM – 12:15PM
Eileen M O’Reilly, MD

Non-Small Cell Lung Cancer
1:00PM – 2:00PM
Gregory Riely, MD

Head and Neck, Thyroid, and Non-Melanoma Skin Cancers
2:00PM – 3:00PM
Lara Dunn, MD

Anal and Rectal Cancers
3:00PM – 3:45PM
Andrea Cercek, MD

Esophageal and Gastric Cancers
3:45PM – 4:30PM
David Ilson, MD, PhD

Central Nervous System Tumors
4:30PM – 5:00PM
Thomas Kaley, MD

Sarcoma
5:00PM – 5:45PM
Robert G Maki, MD, PhD

Infectious Disease
5:45PM – 6:15PM
Susan Seo, MD

Sunday, March 9, 2025

Pharmacology I_II PT. 1
7:00AM – 9:00AM
Mrinal Gounder, MD

Pharmacology I_II PT. 2
7:00AM – 7:10AM
Mrinal Gounder, MD

Acute Myeloid Leukemia
9:10AM – 9:50AM
Eytan Stein, MD

Low-Grade Non-Hodgkin Lymphoma
9:50AM – 10:30AM
Andrew D Zelenetz, MD, PhD

Chronic Lymphocytic Leukemia _Small Lymphocytic Lymphoma
10:30AM – 11:10AM
Meghan C Thompson, MD

Diffuse Large B-Cell Lymphoma _Mantle Cell Lymphoma _Burkitt Lymphoma
11:10AM – 12:10PM
Paul A Hamlin, MD

Hodgkin Lymphoma _ T Cell
12:40PM – 1:40PM
Alison Moskowitz, MD

Auto _Allo
1:40PM – 2:20PM
Gunjan Shah , MD, MS

CAR T Cells
2:20PM – 2:50PM
Craig Sauter, MD

Acute Lymphocytic Leukemia
2:50PM – 3:20PM
Mark B Geyer , MD

Myeloproliferative Neoplasms
3:40PM – 4:05PM
Raajit Rampal, MD, PhD

Myelodysplastic
4:05PM – 4:30PM
Aaron D Goldberg, MD

Chronic Myelogenous Leukemia
4:30PM – 5:00PM
Michael Mauro, MD

Myeloma _Amyloid
5:00PM – 6:00PM
Malin Hultcrantz, MD, PhD

Monday, March 10, 2025

Approach to the Bleeding Patient
8:05AM – 8:50AM
Avi Leader, MD

Thrombotic Disorders
8:50AM – 9:50AM
Jeffrey Zwicker, MD

Antithrombotic and Antiplatelet Therapy
9:50AM – 10:30AM
Simon Mantha, MD, MPH

Thrombocytopenia and ITP
10:30AM – 11:00AM
Cy R Wilkins, MD

Sickle Cell Disease, Thalassemia
11:00AM – 12:00PM
Susanna Curtis, MD, PhD

Hemolytic Anemia
12:30PM – 1:05PM
Gerald Soff, MD

Clinical Indications for Use of Blood Products and Associated Risks
1:05PM – 2:00PM
P. Dayand D Borge Jr., MD, PhD

Transfusion Reactions
2:00PM – 2:45PM
Grace E Linder, MD